Skip to main content
. Author manuscript; available in PMC: 2021 Jun 4.
Published in final edited form as: J Pharm Sci. 2020 Sep 7;110(1):347–353. doi: 10.1016/j.xphs.2020.09.004

Table 2.

Ki Values for 19 Parent Drugs.

Drug Molecular Weight (g/mol)a Ki (μM)
Potency (hOAT3/hOAT1)
OAT1 OAT3

Indomethacin 357.788 4.35 0.11 39.5
Sulindac 356.411 56.8 1.65 34.4
Losartan 422.911 11.4 0.36 31.7
Glyburide 494.004 5.7 0.21 27.1
Meloxicam 351.401 6.88 0.54 12.7
Rosiglitazone 357.427 4.2 0.59 7.12
Trazodone 371.864 19.9 2.94 6.77
Probenecid 285.359 7.74 1.25 6.19
Pioglitazone 356.439 6.3 1.02 6.18
Chlorzoxazone 169.565 52.3 10.2 5.13
Warfarin 308.3279 15.8 3.11 5.08
Tolmetin 257.2845 3.01 0.81 3.72
Diclofenac 296.149 1.67 0.62 2.69
Imatinib 493.6027 29.2 14.5 2.01
Ketoprofen 254.2806 1.73 1.61 1.07
Flurbiprofen 244.2609 1.91 1.8 1.06
Naproxen 230.2592 3.23 4.75 0.68
Celecoxib 381.372 >200 >200 NA
Abiraterone 349.509 >20 >20 NA

NA: Not available.

a

Data from Drugbank or PubChem.